International Stem Cell CORP (ISCO) stock
ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.28+0.00 (+0.89%)
Close on Oct 19, 2026Market cap $2.27MP/E –Yield –
International Stem Cell statistics
44 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 0.51%
- 10.9%
- Shares Change (QoQ)
- 0.00%
- 0.48%
- Float
- 8M
- 49M
- Shares Held by Insiders
- 0.46%
- 12.1%
MarginsIndustry
- EBITDA Margin
- -2.86%
- -27.7%
- FCF Margin
- 3.50%
- -8.85%
Returns on capitalIndustry
- Return on Assets (ROA)
- -11.0%
- -40.7%
- Return on Capital Employed (ROCE)
- -616.7%
- -38.1%
Financial positionIndustry
- Current Ratio
- 0.79
- 3.30
- Quick Ratio
- 0.41
- 2.40
- Interest Coverage
- -3.15
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 3.40%
- 7.26%
- FCF Growth (YoY)
- 851.4%
- 7.48%
- Revenue Growth (3Y CAGR)
- 3.62%
- 2.25%
- Revenue Growth (5Y CAGR)
- 5.01%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 1.79
- 0.40
- Inventory Turnover
- 2.65
- 2.73
- Revenue Per Employee
- $288.30K
- $429.38K
- Profits Per Employee
- -$17.64K
- -$683.67K
- Employee Count
- 33
- 75
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $1.09M
- $16.56M
- Net Cash Per Share
- $0.14
- $0.71
- Equity (Book Value)
- -$4.23M
- $52.23M
- Book Value Per Share
- -$0.53
- $1.50
- Tangible Book Value
- -$4.74M
- $26.10M
- Working Capital
- -$1.06M
- $78.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$36.00K
- -$944.00K
- FCF Per Share
- $0.04
- -$0.42
Taxes and interestIndustry
- Interest Expense
- $141.00K
- $2.98M
Scores and fair valueIndustry
- Piotroski F-Score
- 5
- 4
- Beneish M-Score
- -3.20
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | ISCO | S&P 500 | Difference | ISCO per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -13.2% | +0.6% | −13.8 pts | ||
| 3 months | +57.2% | +3.4% | +53.8 pts | ||
| Year to date | +102.1% | +13.3% | +88.9 pts | ||
| 1 year | +88.7% | +16.6% | +72.1 pts | ||
| 3 years | +117.7% | +86.4% | +31.3 pts | +29.6% | +23.1% |
| 5 years | -45.6% | +81.9% | −127.4 pts | -11.5% | +12.7% |
| 10 years | -84.3% | +318.9% | −403.1 pts | -16.9% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M ISCO shares were sold short on Oct 30, 2026, up 0.0% from the previous report. At recent volumes it would take 1.0 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 48 | 0.0% | 107,306 | 1.0 |
| Oct 15, 2026 | 48 | 0.0% | 5,379 | 1.0 |
| Sep 30, 2026 | 48 | 0.0% | 30,589 | 1.0 |
| Sep 15, 2026 | 48 | -94.1% | 124,095 | 1.0 |
| Aug 31, 2026 | 808 | -89.7% | 92,036 | 1.0 |
| Aug 14, 2026 | 7,881 | +345.3% | 7,497 | 1.1 |
| Jul 31, 2026 | 1,770 | +178.7% | 58,000 | 1.0 |
| Jul 15, 2026 | 635 | -90.5% | 15,938 | 1.0 |
| Jun 30, 2026 | 6,699 | -51.1% | 7,053 | 1.0 |
| Jun 15, 2026 | 13,705 | -17.1% | 1,472 | 9.3 |
| May 29, 2026 | 16,525 | -0.5% | 180 | 91.8 |
| May 15, 2026 | 16,612 | +93.5% | 4,812 | 3.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?